IN2012DN01414A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01414A
IN2012DN01414A IN1414DEN2012A IN2012DN01414A IN 2012DN01414 A IN2012DN01414 A IN 2012DN01414A IN 1414DEN2012 A IN1414DEN2012 A IN 1414DEN2012A IN 2012DN01414 A IN2012DN01414 A IN 2012DN01414A
Authority
IN
India
Prior art keywords
nitroimidazooxazines
drugs
alone
novel
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
William Alexander Denny
Andrew M Thompson
Adrian Blaser
Zhenkun Ma
Brian Desmond Palmer
Hamish Scott Sutherland
Iveta Kmentova
Original Assignee
Global Alliance For Tb Drug Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Alliance For Tb Drug Dev filed Critical Global Alliance For Tb Drug Dev
Publication of IN2012DN01414A publication Critical patent/IN2012DN01414A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IN1414DEN2012 2009-07-31 2010-07-30 IN2012DN01414A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23039609P 2009-07-31 2009-07-31
PCT/US2010/043906 WO2011014774A1 (en) 2009-07-31 2010-07-30 Nitroimidazooxazines and their uses in anti-tubercular therapy

Publications (1)

Publication Number Publication Date
IN2012DN01414A true IN2012DN01414A (ko) 2015-06-05

Family

ID=42937154

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1414DEN2012 IN2012DN01414A (ko) 2009-07-31 2010-07-30

Country Status (12)

Country Link
EP (1) EP2459571B1 (ko)
JP (1) JP5781072B2 (ko)
KR (1) KR101746482B1 (ko)
CN (1) CN102753558B (ko)
AU (1) AU2010278777B2 (ko)
BR (1) BR112012002278A2 (ko)
CA (1) CA2769359C (ko)
ES (1) ES2536997T3 (ko)
IN (1) IN2012DN01414A (ko)
NZ (1) NZ598121A (ko)
RU (1) RU2542988C2 (ko)
WO (1) WO2011014774A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103596960B (zh) * 2011-04-15 2016-11-16 大塚制药株式会社 6,7-二氢咪唑并[2,1-b][1,3]噁嗪杀菌剂
CN104059082B (zh) * 2013-03-21 2016-08-03 苏州迈泰生物技术有限公司 硝基咪唑杂环类化合物及其在制备治疗结核病药物中的应用
KR101682356B1 (ko) 2014-11-04 2016-12-06 한국화학연구원 이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물
CN107207532B (zh) 2015-01-29 2019-07-30 南京明德新药研发股份有限公司 抗肺结核病的硝基咪唑衍生物
CN108047248A (zh) * 2018-02-12 2018-05-18 丹诺医药(苏州)有限公司 噁唑烷酮-硝基咪唑类偶联分子的应用
CN113527331B (zh) * 2020-04-17 2024-05-28 南京长澳医药科技有限公司 硝基咪唑类衍生物及其制备方法和用途
CN113355439A (zh) * 2021-06-07 2021-09-07 深圳市普瑞康生物技术有限公司 一种结核分枝杆菌潜伏感染及发病的新型组合检测方法
CN114469946B (zh) * 2022-02-24 2023-10-24 首都医科大学附属北京胸科医院 德拉马尼作为cxcl10抑制剂的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184739A1 (en) 1994-03-08 1995-09-14 Jay E. Wrobel Thiazolidinedione derivatives as anti-hyperglycemic agents
US5668127A (en) * 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
US6087358A (en) 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
AR041198A1 (es) * 2002-10-11 2005-05-04 Otsuka Pharma Co Ltd Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen
CN100497345C (zh) * 2003-10-31 2009-06-10 大塚制药株式会社 治疗结核病的2,3-二氢-6-硝基咪唑并[2,1-b]唑化合物
DE602005004040T2 (de) 2004-01-16 2008-12-11 Sumitomo Chemical Co., Ltd. Malononitrilverbindungen als Pestizide
TWI300409B (en) * 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
WO2006043121A1 (en) * 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
CN101268084A (zh) * 2005-07-28 2008-09-17 沃泰克斯药物股份有限公司 天冬氨酸特异性半胱氨酸蛋白酶抑制剂前体药物
US20080275035A1 (en) * 2005-12-23 2008-11-06 Jan Jiricek Nitroimidazole Compounds
WO2009120789A1 (en) * 2008-03-26 2009-10-01 Global Alliance For Tb Drug Development Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones

Also Published As

Publication number Publication date
CA2769359A1 (en) 2011-02-03
JP2013500996A (ja) 2013-01-10
CN102753558A (zh) 2012-10-24
EP2459571A1 (en) 2012-06-06
KR101746482B1 (ko) 2017-06-27
AU2010278777B2 (en) 2015-05-07
BR112012002278A2 (pt) 2020-09-15
CA2769359C (en) 2017-03-07
CN102753558B (zh) 2014-10-15
RU2542988C2 (ru) 2015-02-27
NZ598121A (en) 2013-04-26
KR20120084713A (ko) 2012-07-30
AU2010278777A1 (en) 2012-03-01
WO2011014774A1 (en) 2011-02-03
JP5781072B2 (ja) 2015-09-16
ES2536997T3 (es) 2015-06-01
RU2012107176A (ru) 2013-09-10
EP2459571B1 (en) 2015-03-11

Similar Documents

Publication Publication Date Title
MX2012010671A (es) Compuestos antiinfecciosos.
IN2012DN01414A (ko)
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
PH12016500207A1 (en) Anti-infective compounds
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
EP2730576A3 (en) Anti-infective compounds
PL2748165T3 (pl) Pochodne 1,6-diazabicyklo[3,2,1]oktan-7-onu i ich zastosowanie w leczeniu zakażeń bakteryjnych
EP2536406A4 (en) BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, COMPRISING THE TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
WO2009140309A3 (en) Boron-containing small molecules
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
ZA201307963B (en) 1,6- diazabicyclo [3,2,1] octan-7 one derivatives and their use in the treatment of bacterial infections
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
MX2012001156A (es) Moleculas que contienen boro trisustituidas.
MY176900A (en) Antimicrobial compounds and methods of making and using the same
WO2011085990A8 (en) Anti - infective pyrido (1,2 -a) pyrimidines
MX363678B (es) Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
PH12015502375B1 (en) Antimicrobial compounds and methods of making and using the same
MX342226B (es) Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.
MY165011A (en) Antimicrobial compounds and methods of making and using the same
WO2013166282A3 (en) Methods and compositions for treating bacterial infection
MX360411B (es) Uso de tiosulfato para potenciar el efecto anti-patogenico de los lactobacilos.
PH12014501239A1 (en) Thymol and totarol antibacterial composition